Cancer’s Power Hubs: New Research and Targeted Therapies
“`html
RNA ‘Hubs’ Fuel Aggressive Kidney Cancer, Texas A&M Study Finds
Table of Contents
The Discovery: RNA as a Structural Component of Cancer Growth
In cities, coworking spaces bring people together to collaborate and innovate. Inside cancer cells, a similar concept plays out — but with deadly consequences. Scientists at the Texas A&M University Health Science center (Texas A&M Health) have discovered that within the cells of a rare and aggressive kidney cancer, tiny molecular “hubs” form that accelerate disease instead of progress.
Their study, published in Nature Communications, reveals that RNA, typically known for transmitting genetic messages, can be hijacked to build liquid-like “droplet hubs” inside the cell nucleus. These droplets act as command centers that activate growth-related genes. The team not onyl observed this phenomenon but also developed a molecular switch that can dissolve these hubs on demand, effectively cutting off the cancer’s growth mechanism at its core.
RNA Becomes Cancer’s Builder
the researchers focused on a rare kidney cancer called translocation renal cell carcinoma (tRCC), which primarily affects children and young adults and currently lacks effective treatments. This cancer results from TFE3 oncofusions — abnormal hybrid genes created when chromosomes break and fuse incorrectly.
Until now, scientists did not fully understand how these fusion proteins made tRCC so aggressive. The Texas A&M team found that the fusions enlist RNA to serve as a structural framework. Rather of merely carrying messages, RNA molecules assemble into droplet-like condensates that cluster vital molecules together. These droplets then act as transcriptional hubs, activating genes that promote tumor growth.
“RNA itself is not just a passive messenger, but an active player that helps build these condensates,” said Yun huang, PhD, professor at the Texas A&M Health Institute of Biosciences and Technology and senior author.
The team also identified an RNA-binding protein called PSPC1,which stabilizes these droplets and makes them even more effective at driving tumor formation.
Uncovering the Mechanism: Cutting-Edge Molecular Biology Tools
To uncover how this process works, the researchers used a suite of cutting-edge molecular biology tools:
- CRISPR gene editing: Used to “tag” fusion proteins in patient-derived cancer cells, allowing researchers to track their location.
- SLAM-seq: A next-generation sequencing method that measures newly made RNA, revealing which genes are switched on or off as the droplets form.
- CUT&Tag and RIP-seq: Techniques used to map where the fusion proteins bind DNA and RNA, revealing